Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Mallinckrodt
Moodys
Merck
Harvard Business School

Last Updated: February 23, 2020

DrugPatentWatch Database Preview

Patent: 8,268,352

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,268,352
Title:Modified release composition for highly soluble drugs
Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
Inventor(s): Vaya; Navin (Gujarat, IN), Karan; Rajesh Singh (Gujarat, IN), Nadkarni; Sunil Sadanand (Gujarat, IN), Gupta; Vinod Kumar (Gujarat, IN)
Assignee: Torrent Pharmaceuticals Limited (Ahmedabad, IN)
Application Number:11/134,632
Patent Claims:see list of patent claims

Details for Patent 8,268,352

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 001 1987-11-13   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 002 1987-11-13   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Genentech CATHFLO ACTIVASE alteplase VIAL 103172 003 1987-11-13   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
Amgen EPOGEN/PROCRIT epoetin alfa VIAL; SINGLE-USE 103234 001 1989-06-01   Start Trial Torrent Pharmaceuticals Limited (Ahmedabad, IN) 2022-08-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Colorcon
Boehringer Ingelheim
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.